Voyager Therapeutics (VYGR) Retained Earnings: 2015-2025
Historic Retained Earnings for Voyager Therapeutics (VYGR) over the last 10 years, with Sep 2025 value amounting to -$418.5 million.
- Voyager Therapeutics' Retained Earnings fell 43.47% to -$418.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$418.5 million, marking a year-over-year decrease of 43.47%. This contributed to the annual value of -$326.2 million for FY2024, which is 24.89% down from last year.
- Voyager Therapeutics' Retained Earnings amounted to -$418.5 million in Q3 2025, which was down 7.14% from -$390.6 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Retained Earnings registered a high of -$261.2 million during Q4 2023, and its lowest value of -$418.5 million during Q3 2025.
- For the 3-year period, Voyager Therapeutics' Retained Earnings averaged around -$316.3 million, with its median value being -$291.7 million (2024).
- In the last 5 years, Voyager Therapeutics' Retained Earnings surged by 33.63% in 2023 and then tumbled by 43.47% in 2025.
- Over the past 5 years, Voyager Therapeutics' Retained Earnings (Quarterly) stood at -$347.1 million in 2021, then decreased by 13.37% to -$393.5 million in 2022, then skyrocketed by 33.63% to -$261.2 million in 2023, then declined by 24.89% to -$326.2 million in 2024, then tumbled by 43.47% to -$418.5 million in 2025.
- Its Retained Earnings stands at -$418.5 million for Q3 2025, versus -$390.6 million for Q2 2025 and -$357.2 million for Q1 2025.